Advertisement

Topics

Companies Related to "review Regeneron sBLA diabetic retinopathy injection" [Most Relevant Company Matches] RSS

07:25 EDT 18th October 2018 | BioPortfolio

Here are the most relevant search results for "review Regeneron sBLA diabetic retinopathy injection" found in our extensive corporate database of over 50,000 company records.

Showing "review Regeneron sBLA diabetic retinopathy injection" Companies 1–25 of 524

Extremely Relevant

Regeneron Pharmaceuticals, Inc.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-re...


VisionQuest Biomedical LLC

VisionQuest Biomedical is a research and development (R&D) company based in Albuquerque, NM. VisionQuest uses artificial intelligence to detect multiple ophthalmic conditions, such as diabetic retinopathy and malarial retinopathy.

Relevant

Georgia Retina, P.C.

The physicians of Georgia Retina specialize in the diagnosis and treatment of diabetic retinopathy, macular pucker and macular holes, age-related macular degeneration, retinal detachment, proliferative vitreoretinopathy, ocular trauma, hereditary macular disease, retinopathy of prematurity and other forms of retinal and vitreous pathologies.


Regeneron Pharmaceuticals

Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of obesity, rheumatoid arthritis, and cancer. The Company also has preclinical programs in asthma, allergies, and other diseases and disorders. Regen...

Regeneron

Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflammation.Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic ca...

Kubota Pharmaceutical Holdings Co., Ltd.

Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) is committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. The company’s development pipeline includes drug candidates and therapeutics for the treatment of retinitis pigmentosa, proliferative diabetic retino...

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide. The company’s orally-delivered VCM therapies, which selectively target cells within the retina to protect visual acui...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of wet age-related macular degeneration, diabetic retinopathy and diabetic macular edema, which together affect nearly si...

Doctor Diabetic Supply, Inc.

Doctor Diabetic Supply, Inc. is a medical supply distribution company headquartered in Miami, FL. Doctor Diabetic Supply employs over 260 people and serves more than 80,000 customers nationwide. The company is a leading direct-to-consumer provider of diabetic testing supplies and related products. Founded in 2001, Doctor Diabetic Supply, Inc. has grown to be one of the largest diabetic supply comp...

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is a small molecule activator of the Tie2 pathway and is in clinical development for diabetic retinopathy.

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide. The Company’s orally delivered VCM compounds, which selectively target cells within the retina to p...

Alteon Incorporated

Alteon is engaged in the discovery and development of pharmaceutical products for the treatment of the complications of diabetes and age-related diseases. Alteon's efforts have focused primarily on developing its lead first-in-class compound, pimagedine, as an agent to inhibit or block abnormal glucose/protein complexes, known as Advanced Glycosylation End-products ("A.G.E.s"), that lead to diabet...

BioStratum Incorporated

BioStratum is focused on the discovery, development and commercialization of novel therapeutic agents for the treatment of diabetes and diabetic complications. BioStratum's pipeline is led by Pyridorin™ a small molecule drug for the treatment of diabetic kidney disease, followed by pre-clinical compounds that will treat other diabetic complications and cancer. Pyridorin has been granted Fast Tra...

Eyenuk, Inc.

Eyenuk, Inc., headquartered in Los Angeles, California, is an AI diagnostic company focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and chronic diseases at the point of care. Using computer vision and machine learning expertise, the company is developing a portfolio of products based on its proprietar...

Alpha Review Corporation

Alpha Review Corporation (ARC) was formed in 1995 as a medical bill review company. ARC customizes its bill review services to meet the client's individual needs by setting specific and unique customer notification parameters, providing customized management reports, and meeting any number of perhaps seemingly minor, but critical needs. This ensures a smoo...

Diabetic Care Services & Pharmacy

Headquartered in Cleveland, Ohio Diabetic Care Services & Pharmacy is one of the nation’s leading mail-order providers of durable medical equipment supplies and prescription medications for diabetes customers and related conditions. For Medicare and private insurance customers, Diabetic Care Services & Pharmacy delivers one-stop shopping, 24/7 persona...

Harvard Business Review

Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published on HBR.org, Harvard Business Review provides professionals around the world with rigorous insights and best practic...

Technology Review

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Technology Review, Inc.

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen deficiency. This new class of drugs can be potentially developed in a broad range of clinical indications where therapeutic benefit can be obtained through an increased, regulated de...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to detect clinically with conventional examination equipment and techniques. Optos' devices produce ultra wide-field, high-resolution images of approximately 82% of the retina, somethi...

Altris.AI

Altris.AI (Altris, Inc) is a company which applies computer vision and deep learning trained algorithms to build innovative ophthalmology diagnosis real-time support platform for the automatic, structural and quantitative analysis and detection of glaucoma, age-related macular degeneration, diabetic retinopathy and other retinal diseases on Optical Coheren...

Techpool Bio-pharma Co., Ltd.

Established in 1993, Techpool Bio-Pharma Co., Ltd. is one of the leading bio-pharma companys in China, with total assets of USD30 million and registered capital of USD11.7 million. We are specializing in R&D, manufacturing and marketing of bio-pharmaceutical products and currently export to Japan, Korea, India, Pakistan, Israel etc. We manufacture the following pharmaceutical products: Finished p...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and gr...

Aciont Inc.

AciontTM Inc. endeavors to become the world leader in commercializing localized, non-invasive and controlled release back-of-the-eye therapeutics for sight threatening diseases. Our name Aciont ("action transport therapeutics") refers to our expertise in controlling drug transport through human membrane tissues. Our Visulex TM technology provides ophthalmologists (and potentially patients thems...


More From BioPortfolio on "review Regeneron sBLA diabetic retinopathy injection"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks